BioSpace News Archive

High disease prevalence across the globe coupled with ongoing research & development is expected to stimulate market growth.

Rising prevalence of cardiovascular disorders, growing awareness about early diagnosis of heart diseases, and increasing investments in research and development activities are key factors boosting global market growth.

IDEAYA Biosciences, Inc. announced the pricing of an underwritten public offering of 4,637,681 shares of its common stock at a public offering price of $17.25 per share, before underwriting discounts and commissions.

The medical community has become increasingly interested in the possibility of using coronavirus test cycle threshold values to improve care for COVID-19 patients and overall management of the pandemic.

Increasing occurrences of chronic diseases is one of the significant factors influencing market growth.

United States Pharmacopeia (USP), an independent, scientific nonprofit organization, is pleased to announce the acquisition of Pharmatech Associates, Inc.

Scientists at the University of North Carolina at Chapel Hill School of Medicine and colleagues have demonstrated that variants in the SPTBN1 gene can alter neuronal architecture, dramatically affecting their function and leading to a rare, newly defined neurodevelopmental syndrome in children.

Waters Corporation will webcast its Q2 2021 financial results conference call live on Tuesday August 3rd, 2021 at 8:00 a.m. eastern time.

Kinnate Biopharma Inc. (Nasdaq: KNTE) (“Kinnate”), a biopharmaceutical company focused on the discovery and development of small molecule kinase inhibitors for difficult-to-treat, genomically defined cancers, today announced that its Chief Executive Officer Nima Farzan will participate in the William Blair Biotech Focus Conference 2021,

10x Genomics announced it will report financial results for the second quarter 2021 after market close on Wednesday, August 4th, 2021.